JILIN AODONG PHARMACEUTICAL GROUP CO., LTD. Funds and ETFs Jilin Aodong Pharmaceutical Group Co., Ltd.
Equities
000623
CNE000000719
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.08 CNY | +2.65% |
|
+2.17% | -0.40% |
| Apr. 17 | Aodong Medicine's 2023 Profit Declines 18%; Revenue Up 20% | MT |
| Apr. 16 | Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
ETFs positioned on Jilin Aodong Pharmaceutical Group Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 117 M€ | +1.11% | - | |
| 0.00% | 7 M€ | +1.95% | - | |
| 0.00% | 31 M€ | +3.50% | - | |
| 0.00% | 34 M€ | +2.14% | - |
Jilin Aodong Pharmaceutical Group Co., Ltd. specializes in the manufacturing and marketing of pharmaceutical products. Besides, the group offers food products. Net sales break down by activity as follows:
- sale of pharmaceutical products (89.4%);
- sale of food products (6.8%);
- other (3.8%).
All sales are in China.
Sector
Pharmaceuticals
Calendar
2024-04-29
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
15.08
CNY
Average target price
22.67
CNY
Spread / Average Target
+50.33%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -0.40% | 2.49B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- 000623 Stock
- Funds and ETFs Jilin Aodong Pharmaceutical Group Co., Ltd.
